TRPV1 Receptor in Expression of Opioid-Induced Hyperalgesia

Anna Vardanyan, Ruizhong Wang, Todd W Vanderah, Michael H. Ossipov, Josephine Lai, Frank Porreca, Tamara King

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Opiates are currently the mainstay for treatment of moderate to severe pain. However, prolonged administration of opiates has been reported to elicit hyperalgesia in animals, and examples of opiate-induced hyperalgesia have been reported in humans as well. Despite the potential clinical significance of such opiate-induced actions, the mechanisms of opiate-induced hypersensitivity remain unknown. The transient receptor potential vanilloid1 (TRPV1) receptor, a molecular sensor of noxious heat, acts as an integrator of multiple forms of noxious stimuli and plays an important role in the development of inflammation-induced hyperalgesia. Because animals treated with opiates show thermal hyperalgesia, we examined the possible role of TRPV1 receptors in the development of morphine-induced hyperalgesia using TRPV1 wild-type (WT) and knock-out (KO) mice and with administration of a TRPV1 antagonist in mice and rats. Administration of morphine by subcutaneous implantation of morphine pellets elicited both thermal and tactile hypersensitivity in TRPV1 WT mice but not in TRPV1 KO mice. Moreover, oral administration of a TRPV1 antagonist reversed both thermal and tactile hypersensitivity induced by sustained morphine administration in mice and rats. Immunohistochemical analyses indicate that sustained morphine administration modestly increases TRPV1 labeling in the dorsal root ganglia. In addition, sustained morphine increased flinching and plasma extravasation after peripheral stimulation with capsaicin, suggesting an increase in TRPV1 receptor function in the periphery in morphine-treated animals. Collectively, our data indicate that the TRPV1 receptor is an essential peripheral mechanism in expression of morphine-induced hyperalgesia. Perspective: Opioid-induced hyperalgesia possibly limits the usefulness of opioids, emphasizing the value of alternative methods of pain control. We demonstrate that TRPV1 channels play an important role in peripheral mechanisms of opioid-induced hyperalgesia. Such information may lead to the discovery of analgesics lacking such adaptations and improving treatment of chronic pain.

Original languageEnglish (US)
Pages (from-to)243-252
Number of pages10
JournalJournal of Pain
Volume10
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Opiate Alkaloids
Hyperalgesia
Morphine
Opioid Analgesics
Hypersensitivity
Hot Temperature
Touch
Knockout Mice
Transient Receptor Potential Channels
Pain
Capsaicin
Spinal Ganglia
Chronic Pain
Oral Administration
Analgesics
Inflammation
Therapeutics

Keywords

  • hyperalgesia
  • knockout
  • morphine
  • opioid
  • TRPV1

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Neurology
  • Clinical Neurology

Cite this

TRPV1 Receptor in Expression of Opioid-Induced Hyperalgesia. / Vardanyan, Anna; Wang, Ruizhong; Vanderah, Todd W; Ossipov, Michael H.; Lai, Josephine; Porreca, Frank; King, Tamara.

In: Journal of Pain, Vol. 10, No. 3, 03.2009, p. 243-252.

Research output: Contribution to journalArticle

Vardanyan, Anna ; Wang, Ruizhong ; Vanderah, Todd W ; Ossipov, Michael H. ; Lai, Josephine ; Porreca, Frank ; King, Tamara. / TRPV1 Receptor in Expression of Opioid-Induced Hyperalgesia. In: Journal of Pain. 2009 ; Vol. 10, No. 3. pp. 243-252.
@article{aef27ee2d9304f47ae7cb52582f27d43,
title = "TRPV1 Receptor in Expression of Opioid-Induced Hyperalgesia",
abstract = "Opiates are currently the mainstay for treatment of moderate to severe pain. However, prolonged administration of opiates has been reported to elicit hyperalgesia in animals, and examples of opiate-induced hyperalgesia have been reported in humans as well. Despite the potential clinical significance of such opiate-induced actions, the mechanisms of opiate-induced hypersensitivity remain unknown. The transient receptor potential vanilloid1 (TRPV1) receptor, a molecular sensor of noxious heat, acts as an integrator of multiple forms of noxious stimuli and plays an important role in the development of inflammation-induced hyperalgesia. Because animals treated with opiates show thermal hyperalgesia, we examined the possible role of TRPV1 receptors in the development of morphine-induced hyperalgesia using TRPV1 wild-type (WT) and knock-out (KO) mice and with administration of a TRPV1 antagonist in mice and rats. Administration of morphine by subcutaneous implantation of morphine pellets elicited both thermal and tactile hypersensitivity in TRPV1 WT mice but not in TRPV1 KO mice. Moreover, oral administration of a TRPV1 antagonist reversed both thermal and tactile hypersensitivity induced by sustained morphine administration in mice and rats. Immunohistochemical analyses indicate that sustained morphine administration modestly increases TRPV1 labeling in the dorsal root ganglia. In addition, sustained morphine increased flinching and plasma extravasation after peripheral stimulation with capsaicin, suggesting an increase in TRPV1 receptor function in the periphery in morphine-treated animals. Collectively, our data indicate that the TRPV1 receptor is an essential peripheral mechanism in expression of morphine-induced hyperalgesia. Perspective: Opioid-induced hyperalgesia possibly limits the usefulness of opioids, emphasizing the value of alternative methods of pain control. We demonstrate that TRPV1 channels play an important role in peripheral mechanisms of opioid-induced hyperalgesia. Such information may lead to the discovery of analgesics lacking such adaptations and improving treatment of chronic pain.",
keywords = "hyperalgesia, knockout, morphine, opioid, TRPV1",
author = "Anna Vardanyan and Ruizhong Wang and Vanderah, {Todd W} and Ossipov, {Michael H.} and Josephine Lai and Frank Porreca and Tamara King",
year = "2009",
month = "3",
doi = "10.1016/j.jpain.2008.07.004",
language = "English (US)",
volume = "10",
pages = "243--252",
journal = "Journal of Pain",
issn = "1526-5900",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - TRPV1 Receptor in Expression of Opioid-Induced Hyperalgesia

AU - Vardanyan, Anna

AU - Wang, Ruizhong

AU - Vanderah, Todd W

AU - Ossipov, Michael H.

AU - Lai, Josephine

AU - Porreca, Frank

AU - King, Tamara

PY - 2009/3

Y1 - 2009/3

N2 - Opiates are currently the mainstay for treatment of moderate to severe pain. However, prolonged administration of opiates has been reported to elicit hyperalgesia in animals, and examples of opiate-induced hyperalgesia have been reported in humans as well. Despite the potential clinical significance of such opiate-induced actions, the mechanisms of opiate-induced hypersensitivity remain unknown. The transient receptor potential vanilloid1 (TRPV1) receptor, a molecular sensor of noxious heat, acts as an integrator of multiple forms of noxious stimuli and plays an important role in the development of inflammation-induced hyperalgesia. Because animals treated with opiates show thermal hyperalgesia, we examined the possible role of TRPV1 receptors in the development of morphine-induced hyperalgesia using TRPV1 wild-type (WT) and knock-out (KO) mice and with administration of a TRPV1 antagonist in mice and rats. Administration of morphine by subcutaneous implantation of morphine pellets elicited both thermal and tactile hypersensitivity in TRPV1 WT mice but not in TRPV1 KO mice. Moreover, oral administration of a TRPV1 antagonist reversed both thermal and tactile hypersensitivity induced by sustained morphine administration in mice and rats. Immunohistochemical analyses indicate that sustained morphine administration modestly increases TRPV1 labeling in the dorsal root ganglia. In addition, sustained morphine increased flinching and plasma extravasation after peripheral stimulation with capsaicin, suggesting an increase in TRPV1 receptor function in the periphery in morphine-treated animals. Collectively, our data indicate that the TRPV1 receptor is an essential peripheral mechanism in expression of morphine-induced hyperalgesia. Perspective: Opioid-induced hyperalgesia possibly limits the usefulness of opioids, emphasizing the value of alternative methods of pain control. We demonstrate that TRPV1 channels play an important role in peripheral mechanisms of opioid-induced hyperalgesia. Such information may lead to the discovery of analgesics lacking such adaptations and improving treatment of chronic pain.

AB - Opiates are currently the mainstay for treatment of moderate to severe pain. However, prolonged administration of opiates has been reported to elicit hyperalgesia in animals, and examples of opiate-induced hyperalgesia have been reported in humans as well. Despite the potential clinical significance of such opiate-induced actions, the mechanisms of opiate-induced hypersensitivity remain unknown. The transient receptor potential vanilloid1 (TRPV1) receptor, a molecular sensor of noxious heat, acts as an integrator of multiple forms of noxious stimuli and plays an important role in the development of inflammation-induced hyperalgesia. Because animals treated with opiates show thermal hyperalgesia, we examined the possible role of TRPV1 receptors in the development of morphine-induced hyperalgesia using TRPV1 wild-type (WT) and knock-out (KO) mice and with administration of a TRPV1 antagonist in mice and rats. Administration of morphine by subcutaneous implantation of morphine pellets elicited both thermal and tactile hypersensitivity in TRPV1 WT mice but not in TRPV1 KO mice. Moreover, oral administration of a TRPV1 antagonist reversed both thermal and tactile hypersensitivity induced by sustained morphine administration in mice and rats. Immunohistochemical analyses indicate that sustained morphine administration modestly increases TRPV1 labeling in the dorsal root ganglia. In addition, sustained morphine increased flinching and plasma extravasation after peripheral stimulation with capsaicin, suggesting an increase in TRPV1 receptor function in the periphery in morphine-treated animals. Collectively, our data indicate that the TRPV1 receptor is an essential peripheral mechanism in expression of morphine-induced hyperalgesia. Perspective: Opioid-induced hyperalgesia possibly limits the usefulness of opioids, emphasizing the value of alternative methods of pain control. We demonstrate that TRPV1 channels play an important role in peripheral mechanisms of opioid-induced hyperalgesia. Such information may lead to the discovery of analgesics lacking such adaptations and improving treatment of chronic pain.

KW - hyperalgesia

KW - knockout

KW - morphine

KW - opioid

KW - TRPV1

UR - http://www.scopus.com/inward/record.url?scp=60849105649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60849105649&partnerID=8YFLogxK

U2 - 10.1016/j.jpain.2008.07.004

DO - 10.1016/j.jpain.2008.07.004

M3 - Article

C2 - 18774343

AN - SCOPUS:60849105649

VL - 10

SP - 243

EP - 252

JO - Journal of Pain

JF - Journal of Pain

SN - 1526-5900

IS - 3

ER -